Scientific Program

Conference Series LLC Ltd invites all the participants across the globe to attend 29th World Congress on Nutrition and Food Sciences Paris, France.

  • Clinical Nutrition
Location: Hall 1
Speaker
Biography:

Giannopoulou is a Senior Lecturer in Exercise, Health and Nutrition Science in the University of Brighton, School of Sport and Service Management in the United Kingdom. Her research is focused on the effects of exercise and nutrition on the overall health and wellbeing of older women and obese and clinical populations with cardiovascular diseases, type 2 diabetes and mental health. She has published more than 20research papers in reputable research journals and has been serving as an Editorial Board Member in peerreviewed journals like Frontiers of Nutrition, Obesity Research and European Journal of Nutrition.

Abstract:

Menopause dramatically increases the risk of obesity and related chronic diseases. Preventive lifestyle interventions of exercise and diet can have cardiometabolic protective effects in this high risk population. High intensity interval exercise (HIIE) has been recently shown to be an advantageous exercise mode as it requires less time and it can lead to faster health improvements compared to continuous exercise (CE). However, no studies have investigated whether HIIE can lead to enhanced fat oxidation rates and exercise enjoyment in older women. The purpose of the present study is to compare the acute effects of CE versus HIIE on fat oxidation and exercise enjoyment in overweight perimenopausal women. Seven perimenopausal women (age: 45.1±1.8 yrs, fat mass: 37.8±2.2%) completed a baseline VO2 peak test and two experimental trials: HIIE and CE. HIIE consisted of eight alternating intervals of 4-minutes walking at 90% heart rate peak (HRP) and 3-minutes at 70% HRP for a total exercise time of 28 minutes. To ensure similar energy expenditure, CE consisted of walking at 70% HRP for 47 minutes. Similar rates of fat oxidation during exercise were found between the two trials. Both trials led to similar scores in exercise enjoyment ((HIIE: 4.9 vs. CE: 3.7, p=0.11), while the HIIE led to slightly greater levels of perceived exertion (HIIE: 14.1 Vs. CE: 13.1, p=0.01). In conclusion, an acute session of HIIE can lead to similar benefits in fat oxidation and exercise enjoyment as the traditionally prescribed CE, while requesting participants to exercise for considerably less time.

Speaker
Biography:

Dr.Manfred Eggersdorfer is Senior Vice President for Nutrition Science & Advocacy at DSM. DSM Nutritional Products is the world leader in vitamins, carotenoids and nutritional ingredients for Human Nutrition, Animal Nutrition and Personal Care.

Prior to DSM, Manfred Eggersdorfer was working for BASF, Ludwigshafen in different positions including Head of Research and Development Fine Chemicals.

Abstract:

Manfred Eggersdorfer studied chemistry at the Technical University Munich and did his PhD in organic chemistry in the field of synthesis and characterization of unusual amino acid. He was post-doc at the Stanford-University, California working with Carl Djerassi on the isolation and characterization of sterols from marine origin.

Further Manfred Eggersdorfer is active as honorary professor at the Faculty of Medical Sciences at the University of Groningen. He is member of the Advisory Board of the Johns Hopkins Bloomberg School of Public Health, of the Fraunhofer-Gesellschaft Curatorial for Innovation, and affiliate of various other organizations. He is author of numerous publications in the fields of vitamins, innovation in nutritional ingredients, and renewable resources, reviewer for a variety of journals and associate editor of the “International Journal of Vitamin and Nutrition Research”.

Speaker
Biography:

Sophie McFarland is a distinguished academic and researcher at Coventry University, UK, specializing in the fields of nutrition science and food technology. With a strong background in dietetics and public health, her work bridges the gap between research innovation and practical applications aimed at improving global health outcomes.

Abstract:

Approximately 26 million people in the United Kingdom are living with one long-term condition and 10 million are living with two or more; these figures are projected to continue increasing (NHS England 2018). People with long-term conditions are two to three times more likely to have poor psychological wellbeing and utilise 50% of GP appointments, 64% of outpatient appointments and over 70 of inpatient bed days. Research in this population could help with increasing constraints on healthcare budgets and resources. Technology-enabled healthcare in the community might help improve quality of life and reduce healthcare costs of managing chronic disease but the overall impact is unclear, we therefore conducted a systematic review.

Speaker
Biography:

Dr. Maria Papamichael is a respected academic and researcher affiliated with La Trobe University in Greece, specializing in nutrition science and public health. With a robust background in clinical nutrition and metabolic health, her research focuses on the intersection of diet, chronic disease prevention, and population health.

Maria’s work emphasizes the role of the Mediterranean diet and other culturally relevant dietary patterns in managing and preventing non-communicable diseases such as diabetes, cardiovascular diseases, and obesity. Her innovative studies explore the biochemical and physiological impacts of dietary interventions, bridging the gap between traditional nutritional practices and modern healthcare.

Abstract:

In clinical practice, biomarkers can provide complementary information to conventional pulmonary tests, symptoms, spirometry, exhaled nitric oxide, PC20 methacholine and histamine . They are useful in establishing diagnosis, monitoring of the disease progression and in response to treatment. The development of non-invasive sampling methods and detection techniques for the identification of components involved in airway inflammation including the determination of biomarkers would greatly contribute to our current insight in airway inflammation associated with various asthma phenotypes as well as to customize individually-targeted therapies. In children reliable non-invasive biomarkers would be valuable.

We applied metabolomic analysis to study the association between urinary organic acid concentrations and pulmonary function in 72 Caucasian children (5-12 years) with asthma determined by gas chromatography and mass.

Dr.Anna Omtzigt

University of Amsterdam, Netherlands

Title: Risk of drug-induced congenital defects
Speaker
Biography:

Anna Omtzigt is an accomplished professional and academic recognized for her contributions to field of expertise, e.g., nutrition science, food technology, or related fields. With a deep commitment to advancing knowledge and innovation, Anna has dedicated her career to addressing key challenges in specific focus area, e.g., dietary sustainability, public health nutrition etc.

Her work often bridges the gap between research and practice, focusing on key interests or areas, such as improving dietary guidelines, promoting food security, or developing functional foods. Anna has collaborated with leading institutions and organizations to foster impactful research that enhances health outcomes and fosters sustainable food systems.

Abstract:

Defects attributable to drug therapy represent about 1% of congenital defects of known aetiology. This means that a precautionary attitude and correct use of drugs in fertile, and especially pregnant, women is a feasible form of prevention. Drugs currently in use with proven teratogenic effect number approximately 25, but new pharmaceutical drugs are constantly in preparation. Recognition of a drug-induced teratogenic effect is a complex procedure taking into account not only experimental animal data but also experience in humans. Considering that 40% of pregnancies are not planned, it follows that any drug with known or suspected teratogenic potential must be used only under strict medical control. Also, adequate knowledge on potential teratogenicity of a drug permits modification of therapy before conception. It goes without saying that any drug should be used during pregnancy only if it is essential, and it would be prudent to use only those where adequate information is provided and prior clinical experience is available. Teratology Information Services can assist both physicians and patients when any doubt exists.

Speaker
Biography:

In the face of rapidly evolving societal challenges, mental health and emotional resilience are critical components of individual and collective well-being. This presentation delves into the psychological frameworks and strategies necessary for fostering resilience, particularly among vulnerable populations such as children, adolescents, and individuals facing life crises. By integrating evidence-based practices and cultural sensitivity, Dr. Javier Urra Portillo explores how to effectively address mental health challenges and empower individuals to navigate the complexities of modern life. Key topics include the impact of social determinants on mental health, the role of preventative interventions, and the importance of fostering emotional intelligence within educational and healthcare systems.

Abstract:

Dr. Javier Urra Portillo is a distinguished expert in psychology and mental health, with a focus on emotional resilience and the well-being of children and adolescents. A prominent academic, clinician and author, Dr. Urra has contributed extensively to understanding the psychological impacts of modern societal pressures and the development of interventions aimed at promoting mental health across diverse populations.

Dr. Urra has held esteemed positions in academic and clinical settings, where he has combined research, teaching and public outreach to address critical issues in mental health. He is a prolific author, having published numerous books and articles on psychology, child development and emotional well-being. His work is highly regarded for its emphasis on ethical practices, empathy, and innovative approaches to mental health care.

  • PublicHealth Nutrition
Location: Hall 2

Session Introduction

Dr.George Siragakis

University Hospital of Larissa, Greece

Title: Advancing Innovation in medical research and nutrition
Speaker
Biography:

Dr. George Siragakis is a distinguished expert in medicine, nutrition, or technology, with a robust academic and professional background that spans research, education, and practical application. A leading figure in specific area, Dr. Siragakis has dedicated his career to advancing innovative solutions that address critical global challenges.

As a professor, researcher, or practitioner at institution or organization,Dr. Siragakis has spearheaded numerous initiatives that have significantly contributed to specific impact, e.g., improving healthcare outcomes, advancing food sustainability, etc. He is an accomplished author and speaker, having published extensively in peer-reviewed journals and delivered keynote presentations at international conferences.

Abstract:

Dr. George Siragakis’ presentation focuses on the latest advancements and innovations in specific area of expertise, e.g., medical research, nutrition, technology, or education. Highlighting key breakthroughs and their practical applications, the session explores how interdisciplinary approaches can solve complex challenges in specific field. By integrating research insights with real-world case studies, Dr. Siragakis demonstrates the transformative potential of cutting-edge solutions in shaping the future of the industry. Attendees will gain actionable insights and a deeper understanding of emerging trends that are redefining the field.

Speaker
Biography:

Dr. Aleksandra Drozd-Rzoska is a respected expert in specific field, e.g., chemistry, food science, or healthcare, known for her innovative research and dedication to advancing knowledge in her discipline. Affiliated with [institution or organization, she has established herself as a leader in specific area of expertise, contributing to significant breakthroughs that address pressing global issues.

As an accomplished researcher and educator, Dr. Drozd-Rzoska has published numerous peer-reviewed articles in high-impact journals and presented her findings at prestigious conferences worldwide. Her work emphasizes the importance of interdisciplinary collaboration and its role in driving progress and innovation.

Abstract:

Dr. Aleksandra Drozd-Rzoska’s presentation highlights transformative advancements in specific area, e.g., scientific research, healthcare, food technology, etc. By addressing critical challenges and leveraging interdisciplinary approaches, her work paves the way for innovative solutions that impact both academic research and practical applications. This session will delve into emerging trends, cutting-edge methodologies, and their implications for the specific industry or global challenges. Attendees will gain valuable insights into the future of the field and practical strategies to enhance outcomes.

Speaker
Biography:

Dr. Luca Roncati is a distinguished pathologist and academic affiliated with the University of Modena and Reggio Emilia, Italy. He specializes in the fields of forensic and clinical pathology, contributing extensively to the understanding of disease mechanisms and medico-legal investigations. Dr. Roncati has published numerous peer-reviewed articles in high-impact journals, with a focus on innovative diagnostic techniques and their applications in clinical practice.

Dr. Roncati is also actively involved in teaching and mentoring students, fostering the next generation of medical professionals. His research integrates cutting-edge technologies with traditional pathological methodologies, providing valuable insights into both complex cases and routine diagnostics. Recognized for his contributions to pathology, Dr. Roncati is frequently invited to speak at international conferences, where he shares his expertise on the latest advancements in his field.

Abstract:

Dr. Luca Roncati’s presentation explores recent advancements in forensic and clinical pathology, focusing on the integration of innovative diagnostic techniques with traditional methods. The session addresses the evolving challenges in pathology, including complex disease mechanisms and medico-legal cases, highlighting the role of interdisciplinary collaboration in advancing the field. By examining case studies and cutting-edge research, Dr. Roncati demonstrates how emerging technologies, such as digital pathology and molecular diagnostics, are shaping the future of pathology. Attendees will gain valuable insights into current trends, best practices, and practical applications that enhance diagnostic accuracy and patient care.

Speaker
Biography:

Dr. Sunil Dadlani's presentation focuses on the latest innovations in specific area, e.g., healthcare technology, medical research, public health, or clinical practice. The session will explore how cutting-edge advancements are reshaping the healthcare landscape, particularly in [specific subfields, e.g., diagnostics, patient care, telemedicine, etc.. Dr. Dadlani will discuss the integration of emerging technologies, data analytics, and patient-centered approaches, and their role in improving health outcomes globally. Attendees will leave with practical insights and strategies for leveraging these innovations in their own professional practices to drive progress in the healthcare sector.

Abstract:

Dr. Sunil Dadlani is an accomplished profession, e.g., medical doctor, healthcare researcher, or public health expert] with a focus on [specific field, such as healthcare innovation, medical technology, or public health. With a background in mention academic training, such as a medical degree, specialized certifications, or postgraduate research, Dr. Dadlani has established himself as a leader in advancing healthcare practices and innovations.

Throughout his career, Dr. Dadlani has contributed to [specific area, e.g., the development of new medical devices, healthcare system reforms, or cutting-edge medical research]. He has published extensively in high-impact journals and has been an advocate for integrating digital solutions into healthcare to improve accessibility and outcomes.

Speaker
Biography:

Dr. Jean Marie Bottequin is an esteemed researcher and academic at Universite Libre de Bruxelles (ULB), Belgium, where he specializes in specific area of research, e.g., molecular biology, biomedical research, or healthcare. With a deep commitment to advancing knowledge in his field, Dr. Bottequin has made significant contributions to the study of specific topics or challenges in his area of expertise. His research focuses on briefly describe research focus, e.g., understanding disease mechanisms, developing innovative therapies, or utilizing emerging technologies to improve healthcare outcomes.

Dr. Bottequin has published extensively in high-impact journals and is recognized for his ability to bridge scientific discovery with real-world applications. His work has garnered international recognition, and he is often invited to present at leading conferences and collaborate with institutions across the globe.

Abstract:

Dr. Jean Marie Bottequin’s presentation will focus on the latest innovations and future directions in specific field, e.g., medical research, molecular biology, or healthcare innovation. Drawing from his extensive research experience, Dr. Bottequin will explore the key challenges facing the field today and present cutting-edge solutions that promise to shape the future of specific area, e.g., disease treatment, technological advancements, or global health initiatives. Through the integration of interdisciplinary approaches and emerging technologies, his work aims to bridge the gap between research and practical application, offering new insights that can drive progress and improve health outcomes worldwide.

Speaker
Biography:

Dr. Robert Elias’ presentation will explore the latest developments and emerging challenges in specific field, e.g., healthcare, medical research, or technology. By examining both current trends and groundbreaking innovations, Dr. Elias will discuss how the integration of specific technologies, methodologies, or interdisciplinary approaches is reshaping the nutrition. He will highlight key advancements and their implications for patient care, clinical practice, disease prevention, or research applications. This session will offer attendees practical insights into how these innovations can be leveraged to address global health challenges and improve outcomes in specific context or population.

Abstract:

Dr. Robert Elias is an esteemed profession, e.g physician, researcher, or healthcare professional with expertise in specific area, e.g.healthcare innovation, clinical research, or medical technology.Where he serves as position or title, e.g., Senior Researcher, Professor or Director. Dr. Elias has made significant contributions to specific field, focusing on specific research areas, technologies, or patient care advancements.

With a background in mention relevant training, such as a medical degree, PhD, or specialized certifications, Dr. Elias has published extensively in leading academic journals and presented his work at numerous international conferences. His research aims to bridge the gap between scientific discovery and real-world applications, contributing to advancements that improve clinical outcomes and enhance healthcare practices worldwide.